V. Kolek

1.5k total citations
28 papers, 515 citations indexed

About

V. Kolek is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, V. Kolek has authored 28 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in V. Kolek's work include Sarcoidosis and Beryllium Toxicity Research (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Lung Cancer Treatments and Mutations (4 papers). V. Kolek is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers) and Lung Cancer Treatments and Mutations (4 papers). V. Kolek collaborates with scholars based in Czechia, United Kingdom and United States. V. Kolek's co-authors include Martin Petřek, František Mrázek, R M du Bois, M. Martinetti, Gianpietro Semenzato, Eva Kriegová, M. Luisetti, A Cipriani, L. Salvaneschi and Carmine Tinelli and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

V. Kolek

26 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Kolek Czechia 12 364 336 84 82 76 28 515
Caroline E. Broos Netherlands 8 399 1.1× 452 1.3× 91 1.1× 90 1.1× 96 1.3× 10 561
Elżbieta Puścińska Poland 9 265 0.7× 210 0.6× 37 0.4× 84 1.0× 39 0.5× 33 385
Yasutaka Ina Japan 8 253 0.7× 199 0.6× 53 0.6× 47 0.6× 63 0.8× 10 353
Seigo Miyoshi Japan 10 205 0.6× 113 0.3× 16 0.2× 83 1.0× 58 0.8× 28 341
Anna Lewandowska‐Polak Poland 11 96 0.3× 194 0.6× 93 1.1× 33 0.4× 55 0.7× 36 380
Rodoula Trigidou Greece 11 295 0.8× 103 0.3× 14 0.2× 85 1.0× 47 0.6× 18 501
Xiao-ning Zhong China 10 146 0.4× 84 0.3× 19 0.2× 49 0.6× 33 0.4× 22 359
Stephen B. Sulavik United States 10 259 0.7× 147 0.4× 16 0.2× 30 0.4× 45 0.6× 16 369
John Wiggins United Kingdom 6 385 1.1× 137 0.4× 8 0.1× 70 0.9× 23 0.3× 11 520
Carian E. Boorsma Netherlands 10 176 0.5× 118 0.4× 11 0.1× 105 1.3× 36 0.5× 14 426

Countries citing papers authored by V. Kolek

Since Specialization
Citations

This map shows the geographic impact of V. Kolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Kolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Kolek more than expected).

Fields of papers citing papers by V. Kolek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Kolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Kolek. The network helps show where V. Kolek may publish in the future.

Co-authorship network of co-authors of V. Kolek

This figure shows the co-authorship network connecting the top 25 collaborators of V. Kolek. A scholar is included among the top collaborators of V. Kolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Kolek. V. Kolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Šonka, Karel, Martin Pretl, J. Václavík, et al.. (2018). Sleep Apnoea in Patients With Nocturnal Hypertension – a Multicenter Study in the Czech Republic. Physiological Research. 67(2). 217–231. 6 indexed citations
3.
Skřičková, Jana, Zbyněk Bortlíček, Miloš Pešek, et al.. (2017). P2.03-023 Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic. Journal of Thoracic Oncology. 12(11). S2136–S2136. 1 indexed citations
4.
5.
Kolek, V.. (2013). Contemporary Trends of the Adjutant Chemotherapy in Non- small Cell Lung Cancer. Klinicka onkologie. 26(4). 245–250.
6.
7.
8.
Kriegová, Eva, Regina Fillerová, Tereza Tománková, et al.. (2011). T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis. European Respiratory Journal. 38(5). 1136–1144. 27 indexed citations
9.
Mrázek, František, et al.. (2011). Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis. Genes and Immunity. 12(6). 490–494. 27 indexed citations
10.
Petřek, Martin, Eva Kriegová, Regina Fillerová, et al.. (2009). Chemokine Network in Pulmonary Sarcoidosis.. A3186–A3186. 1 indexed citations
11.
Mrázek, František, Penny Lympany, Anna L. Lagan, et al.. (2008). The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens. 72(5). 483–486. 4 indexed citations
12.
Mrázek, František, Eva Kriegová, Regina Fillerová, et al.. (2007). Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis. Tissue Antigens. 71(1). 77–80. 9 indexed citations
13.
Kriegová, Eva, Arsen Arakelyan, František Mrázek, et al.. (2006). Expression of CCX CKR in pulmonary sarcoidosis. Inflammation Research. 55(10). 441–445. 11 indexed citations
14.
Mrázek, František, Lýdie Izakovičová Hollá, Beata Hutyrová, et al.. (2005). Association of tumour necrosis factor‐α, lymphotoxin‐α and HLA‐DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens. 65(2). 163–171. 62 indexed citations
15.
Petřek, Martin, et al.. (2002). CC and C chemokine expression in pulmonary sarcoidosis. European Respiratory Journal. 20(5). 1206–1212. 39 indexed citations
16.
Hermans, Cédric, Martin Petřek, V. Kolek, et al.. (2001). Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis. European Respiratory Journal. 18(3). 507–514. 53 indexed citations
17.
Petřek, Martin, P. Pantelidis, AM Southcott, et al.. (1997). The source and role of RANTES in interstitial lung disease. European Respiratory Journal. 10(6). 1207–1216. 53 indexed citations
18.
Martinetti, M., Carmine Tinelli, V. Kolek, et al.. (1995). "The Sarcoidosis Map": A Joint Survey of Clinical and Immunogenetic Findings in Two European Countries. American Journal of Respiratory and Critical Care Medicine. 152(2). 557–564. 120 indexed citations
19.
Hušák, V., et al.. (1992). Absolute quantitation of gallium-67 citrate accumulation in the lungs and its importance for the evaluation of disease activity in pulmonary sarcoidosis. European Journal of Nuclear Medicine and Molecular Imaging. 19(12). 1016–1022. 3 indexed citations
20.
Kolek, V., et al.. (1991). Comparative study of midazolam and diazepam in premedication of bronchoscopy.. PubMed. 131. 233–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline E. Broos Breakdown of academic impact, for papers by Elżbieta Puścińska Breakdown of academic impact, for papers by Yasutaka Ina Breakdown of academic impact, for papers by Seigo Miyoshi Breakdown of academic impact, for papers by Anna Lewandowska‐Polak Breakdown of academic impact, for papers by Rodoula Trigidou Breakdown of academic impact, for papers by Xiao-ning Zhong Breakdown of academic impact, for papers by Stephen B. Sulavik Breakdown of academic impact, for papers by John Wiggins Breakdown of academic impact, for papers by Carian E. Boorsma
Rankless by CCL
2026